Literature DB >> 21395406

Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies.

Kaisar Raza1, Poonam Negi, Shweta Takyar, Anshuman Shukla, Basant Amarji, O P Katare.   

Abstract

The objective of this study was to develop and characterize a novel dithranol-containing phospholipid microemulsion systems for enhanced skin permeation and retention. Based on the solubility of dithranol, the selected oils were isopropyl myristate (IPM) and tocopherol acetate (TA), and the surfactants were Tween 80 (T80) and Tween 20 (T20). The ratios of cosurfactants comprising of phospholipids and ethanol (1 : 10) and surfactant to co-surfactant (1 : 1 and 2.75 : 1) were fixed for the phase diagram construction. Selected microemulsions were evaluated for globule size, zeta potential, viscosity, refractive index, per cent transmittance, stability (freeze thaw and centrifugation), ex vivo skin permeation and retention. The microemulsion systems composed of IPM and T80 with mean particle diameter of 72.8 nm showed maximum skin permeation (82.23%), skin permeation flux (0.281 mg/cm²/h) along with skin retention (8.31%) vis-à-vis systems containing TA and T20. The results suggest that the developed novel lecithinized microemulsion systems have a promising potential for the improved topical delivery of dithranol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21395406     DOI: 10.3109/02652048.2010.546435

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  9 in total

1.  Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies.

Authors:  Bhavesh S Barot; Punit B Parejiya; Hetal K Patel; Dharmik M Mehta; Pragna K Shelat
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

2.  Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design.

Authors:  Bhavesh S Barot; Punit B Parejiya; Hetal K Patel; Mukesh C Gohel; Pragna K Shelat
Journal:  AAPS PharmSciTech       Date:  2011-12-22       Impact factor: 3.246

3.  Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery.

Authors:  Eleni Panoutsopoulou; Jarmila Zbytovská; Kateřina Vávrová; Georgios Paraskevopoulos
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-22

Review 4.  Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.

Authors:  Prativa Biswasroy; Deepak Pradhan; Biswakanth Kar; Goutam Ghosh; Goutam Rath
Journal:  AAPS PharmSciTech       Date:  2021-05-26       Impact factor: 3.246

Review 5.  Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.

Authors:  Kaisar Raza; Manish Kumar; Pramod Kumar; Ruchi Malik; Gajanand Sharma; Manmeet Kaur; O P Katare
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

6.  The effect of nanoemulsion as a carrier of hydrophilic compound for transdermal delivery.

Authors:  Ming-Jun Tsai; Yaw-Syan Fu; Yu-Hsuan Lin; Yaw-Bin Huang; Pao-Chu Wu
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

7.  Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients.

Authors:  Dina Fathalla; Eman M K Youssef; Ghareb M Soliman
Journal:  Pharmaceutics       Date:  2020-05-11       Impact factor: 6.321

8.  Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations and pharmacokinetic studies.

Authors:  Nishtha Chaurawal; Charu Misra; Harshita Abul Barkat; Reena Jatyan; Deepak Chitkara; Md Abul Barkat; Teenu Sharma; Bhupinder Singh; Kaisar Raza
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

Review 9.  Nonsteroidal Topical Immunomodulators in Allergology and Dermatology.

Authors:  Marina Jovanović; Zoran Golušin
Journal:  Biomed Res Int       Date:  2016-04-06       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.